Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna Taps J&J Executive Burton as Medical Chief

06/14/2021 | 08:36am EDT

By Dave Sebastian

Moderna Inc. said it has tapped Paul Burton, a Johnson & Johnson executive, as its chief medical officer, effective July 6.

Dr. Burton served as chief global medical affairs officer of Janssen Pharmaceuticals from March 2020 and spent 16 years with J&J. He would succeed Tal Zaks, who is leaving Moderna after six years of service.

Dr. Burton's entry in the company comes as the company is seeking authorization from various governments' health regulators to authorize the use of its Covid-19 shot in adolescents. Chief Executive Stephane Bancel said results of testing Moderna's vaccine in children as young as five years could become available by the fall, which if positive could lead to regulatory authorization of its use in the younger age group.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

06-14-21 0835ET

Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON 1.10% 174.285 Delayed Quote.9.46%
MODERNA, INC. 11.23% 385.48 Delayed Quote.231.78%
All news about MODERNA, INC.
03:48pMODERNA : U.S. administers 347.4 mln doses of COVID-19 vaccines - CDC
RE
03:39pMODERNA : U.S. CDC Says Delivered 401,229,975 Doses Of Covid-19 Vaccine As Of Au..
RE
10:06aMODERNA : Covid-19 3rd Wave - Federal Govt Declares Lagos, Akwa Ibom, Rivers, Ka..
AQ
09:31aMODERNA : Respiratory Syncytial Virus Vaccine mRNA-1345 Receives FDA Fast-Track ..
MT
09:29aSanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
09:14aMODERNA : Receives FDA Fast Track Designation for Respiratory Syncytial Virus (R..
BU
07:35aSanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
07:34aModerna Gets FDA Fast Track Designation for Respiratory Syncytial Virus Vacci..
DJ
06:06aASTRAZENECA : Sanwo-Olu - Lagos Recorded 4,300 Cases, 30 Fatalities in July
AQ
05:06aMODERNA : Covid-19 - U.S. Delivers 4m Doses Moderna Vaccines to Nigeria to Comba..
AQ
More news
Financials (USD)
Sales 2021 19 117 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 13,7x
Yield 2021 -
Capitalization 139 B 139 B -
EV / Sales 2021 6,66x
EV / Sales 2022 7,45x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 346,61 $
Average target price 187,80 $
Spread / Average Target -45,8%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.231.78%139 174
LONZA GROUP AG25.60%58 688
IQVIA HOLDINGS INC.38.03%47 386
CELLTRION, INC.-26.18%31 285
SEAGEN INC.-11.93%28 062
PHARMARON BEIJING CO., LTD.82.70%24 138